Observational studyEpidemiology and health2023

Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data.

Hong Ki Min et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.